These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7906319)

  • 1. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
    Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
    Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs.
    Takagi T; Takeda M; Maeno H
    Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):49-58. PubMed ID: 6124219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
    Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
    Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
    Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
    Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
    Takeda M; Takagi T; Maeno H
    Eur J Pharmacol; 1983 Aug; 91(4):371-6. PubMed ID: 6137398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
    Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
    Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
    Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB; Tobia AJ; Shriver DA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
    Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
    Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a new potent H2-receptor antagonist 3[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2- sulfamoylpropionamidine (YM-11170) on gastric mucosal histamine-sensitive adenylate cyclase from guinea pig.
    Harada M; Terai M; Maeno H
    Biochem Pharmacol; 1983 May; 32(10):1635-40. PubMed ID: 6134531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and competitive histamine H2-receptor blocking effect of famotidine on the blood pressure response in dogs and the acid secretory response in rats.
    Miyata K; Kamato T; Fujihara A; Takeda M
    Jpn J Pharmacol; 1990 Oct; 54(2):197-204. PubMed ID: 1981794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
    Nagaya H; Inatomi N; Satoh H
    Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisecretory and antiulcer effects of YM020, a new H+,K(+)-ATPase inhibitor, in rats and dogs.
    Yuki H; Kamato T; Nishida A; Ohta M; Shikama H; Yanagisawa I; Miyata K
    Jpn J Pharmacol; 1995 Jan; 67(1):59-67. PubMed ID: 7745846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CP-66,948: an antisecretory histamine H2-receptor antagonist with mucosal protective properties.
    Hakkinen JP; Holt WF; Goddard CJ; Oates PJ; Murphy WR; Maciejko JJ; Reiter LA
    Dig Dis Sci; 1991 Dec; 36(12):1721-8. PubMed ID: 1748041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of an H+, K+-ATPase inhibitor, omeprazole (OPZ), on gastric acid secretion and gastric or duodenal lesion. Comparison with an H2-receptor antagonist, famotidine (FMD)].
    Haga K; Asano K; Osuga K; Maruyama Y
    Nihon Yakurigaku Zasshi; 1988 Jul; 92(1):39-47. PubMed ID: 2906028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a new potent H2-blocker, 3-[[[2-(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoyl propionamidine (YM-11170), on gastric secretion, ulcer formation and weight of male accessory sex organs in rats.
    Takeda M; Takagi T; Yashima Y; Maeno H
    Arzneimittelforschung; 1982; 32(7):734-7. PubMed ID: 6127086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.